Stockscreener 앱 받기
8.69
2.00%
0.17
시간 외 거래:
8.82
0.13
+1.50%
전일 마감가:
$8.52
열려 있는:
$8.63
하루 거래량:
1.99M
Relative Volume:
1.22
시가총액:
$618.64M
수익:
-
순이익/손실:
$-34.98M
주가수익비율:
-9.4467
EPS:
-0.9199
순현금흐름:
$-32.77M
1주 성능:
-1.25%
1개월 성능:
-12.93%
6개월 성능:
+46.30%
1년 성능:
+220.66%
1일 변동 폭
$8.58
$9.3899
1주일 범위
$8.48
$9.785
52주 변동 폭
$1.94
$12.14
Immix Biopharma Inc Stock (IMMX) Company Profile
명칭
Immix Biopharma Inc
전화
(888) 958-1084
주소
11400 WEST OLYMPIC BLVD., LOS ANGELES
Compare IMMX vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
IMMX
Immix Biopharma Inc
|
8.69 | 606.54M | 0 | -34.98M | -32.77M | -0.9199 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
Immix Biopharma Inc Stock (IMMX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-03-25 | 개시 | Morgan Stanley | Overweight |
| 2026-03-09 | 개시 | Citizens | Mkt Outperform |
| 2026-02-09 | 개시 | Mizuho | Outperform |
Immix Biopharma Inc 주식(IMMX)의 최신 뉴스
Immix Biopharma Inc (IMMX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Immix Biopharma Inc (IMMX) Cash Flow - TradingKey
Immix Biopharma, Inc. Revenue Breakdown – NASDAQ:IMMX - TradingView
IMMX|Immix Biopharma Inc|Price:8.680| - TradingKey
TradingKey - TradingKey
Immix Biopharma Inc (IMMX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Immix Biopharma Inc (IMMX) Institutional Confidence - TradingKey
Immix Biopharma Inc (IMMX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Immix Biopharma Inc (IMMX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Immix Biopharma Inc (IMMX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IMMX|Immix Biopharma Inc|Price:9.070|Chg%:+0.550 - TradingKey
Immix Biopharma Inc (IMMX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IMMX|Immix Biopharma Inc|Price:8.593|Chg%:-0.207 - TradingKey
EQPT LAWSUIT: EquipmentShare.com Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton To Learn How They Might Recover Their Losses - GlobeNewswire Inc.
Immix Biopharma, Inc. (IMMX) options chain - Yahoo Finance Australia
symbol__ Stock Quote Price and Forecast - CNN
IMMX Initiated Coverage by Needham -- Rating Set to Buy - GuruFocus
Needham Initiates Immix Biopharma(IMMX.US) With Buy Rating, Announces Target Price $21 - Moomoo
Fugitive doctor on run for 21 years was living as L.A. biotech exec - KTLA
Immix Biopharma drops after chief medical officer terminated - MSN
Sex offender, a fugitive for 21 years, hid in plain sight as a yacht-owning L.A. biopharma exec - Los Angeles Times
Five things for pharma marketers to know for Tuesday, July 21, 2026 - Medical Marketing and Media
IMMX Stock Drops Significantly on Chief Medical Officer News-Immix Biopharma Investors Encouraged to Contact Kehoe Law Firm, P.C. - ACCESS Newswire
Rhode Island fugitive appears to have gotten medical job while on the run - WJAR
Report: RI fugitive likely worked as biotech executive - WPRI.com
IMMX INVESTOR ALERT: Holzer & Holzer, LLC Announces Investigation of Immix Biopharma, Inc. - GlobeNewswire
Immix Biopharma investigated for securities fra... - Pluang
Immix Biopharma Stock Drops Significantly On News of Chief Medical Officer ArrestIMMX Investors Encouraged to Contact Kehoe Law Firm, P.C. Regarding Potential Securities Fraud Claims - TMX Newsfile
IMMX ALERT: Immix Biopharma Investigated for Securities - GlobeNewswire
Immix Biopharma exec fired following arrest after 20 years on the run - Seeking Alpha
Why is Immix Biopharma stock sliding today? By Investing.com - Investing.com Canada
Immix Biopharma stock tumbles amid fugitive CMO report By Investing.com - Investing.com India
Immix Biopharma stock tumbles amid fugitive CMO report - Investing.com
Immix Biopharma Terminates Richard Graydon in 2026 with No Material Business Impact - Minichart
Immix Biopharma (IMMX) reports Richard Graydon’s departure as immaterial event - Stock Titan
Immix Biopharma terminates Richard Graydon employment - Bitget
Immix Biopharma Inc. (IMMX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
What's going on with Immix Biopharma stock Thursday? - MSN
Immix Biopharma’s Big Run Rests On Early CAR-T Data - Finimize
Enterprise value to revenue forward of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
Price to book forward of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
Immix Biopharma, Inc. Financial Disclosures & SEC Filings - TradingView
Wall Street analysts think Immix Biopharma (IMMX) could surge 113.58%: Read this before placing a bet - MSN
Enterprise value to EBIT forward of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
IMMX News | IMMIX BIOPHARMA INC (NASDAQ:IMMX) - ChartMill
Wall Street analysts see a 120.59% upside in Immix Biopharma (IMMX): Can the stock really move this high? - MSN
Immix Biopharma Q1 2026 Earnings: Narrower Net Loss but Stock DeclinesEarnings Season Review - dars.gov.et
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2000 Index - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2500 Growth Benchmark - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2000 Growth Benchmark - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 3000E Growth Benchmark - marketscreener.com
Immix Biopharma Inc (IMMX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.97%
0.83%
자본화:
|
볼륨(24시간):